Fasching PA, Szeto C, Denkert C, Benz S, et al. Inferred immune-cell activity is an independent predictor of HER2 negative breast cancer prognosis and response to paclitaxel-based therapy in the GeparSepto trial. Clin Cancer Res 2023 Apr 4:CCR-22-2213. doi: 10.1158/1078-0432.CCR-22-2213.
PMID: 37014668